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Ribonucleotides can be incorporated into the yeast genome through a variety of 
mechanisms, including through DNA polymerazation, DNA priming, and oxidative 
damage. Ribonucleotides contain a reactive 2’ hydroxyl group on the sugar, which can 
distort the DNA double helix and lead to defective replication and transcription and 
ultimately mutagenesis. Ribonucleotide excision repair (RER) has been found to remove 
ribonucleotides through the enzyme RNase H2, though the in vivo substrate specificity is 
not known. Nucleotide excision repair (NER) removes bulky lesions formed in DNA, 
however its role in the extraction of ribonucleotides has not yet been determined in 
eukaryotes. Previously developed oligonucleotide-driven gene correction assays in 
Saccharomyces cerevisiae, or baker’s yeast, have shown that paired and mispaired 
rNMPs embedded into genomic DNA, if not removed, serve as templates for DNA 
synthesis and can result in a genetic alteration. We implemented this assay to examine 
whether RNase H2 and NER can target specific rNMPs in DNA. Our results deliver new 
evidence that RNase H2 specifically recognizes isolated paired and mispaired rNMPs 
embedded in yeast genomic DNA and that the NER mechanism can recognize an isolated 








Ribonucleotides are the building blocks of RNA, which are a group of molecules 
that drive the transcription, translation, and regulation of genes [1]. Ribonuclease H’s 
(RNase H) remove ribonucleotides that have been mistakenly integrated into the DNA 
chromosome, which is a process essential to stabilizing the genome due to the presence 
of a reactive 2’ hydroxyl group on the ribose sugar of a ribonucleotide [2].  There are two 
types of RNase H enzymes, RNase H1 and H2, the latter being the key player in 
ribonucleotide excision repair (RER) in eukaryotes [4]. Mutations in any of the three 
RNase H2 subunits (rnh201, rnh202, and rnh203) cause a serious neurological disorder 
called Aicardi-Goutiѐres syndrome (AGS) [5]. AGS occurs rarely, however due to its 
pathogenic resemblance to diseases such as lupus and congenital HIV, it is predicted that 
understanding the genetics behind AGS could explain the pathogenesis for these other 
disorders as well [6].  
In this study, we will determine the in vivo substrate specificity of RNase H2 in 
RER and also whether RAD14, a key protein in eukaryotic nucleotide excision repair, 
which focuses on removing DNA bulky lesions, can remove ribonucleotides as well. 
Previous studies have shown in vitro substrate specificities of RNase H2 in which the 
enzyme excises only single ribonucleotides and where RNase H1 excises stretches of 
ribonucleotides [7]. However, no in vivo studies have been performed to support or refute 
this data. Also it is not yet known whether eukaryotic nucleotide excision repair can 
recognize ribonucleotides in addition to DNA bulky lesions [8,12]. We hypothesize that 
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in vivo, both RNase H2 and RAD14 are able to excise paired and mispaired 






 Ribonucleotides are integrated in the DNA during replication or repair, but as 
ribose is a significantly more unstable molecule compared to deoxyribose due to its 2’ 
reactive hydroxyl group, they increase the rate of short deletions in the DNA by 
sensitizing the DNA to enzymatic nicking [2, 3]. Ribonucleotides also alter the double 
helix structure of DNA causing a change in DNA conformation from the B form, with 
equally available major and minor grooves in the double helix, to the A form, with a deep 
major groove in the double helix which could potentially affect DNA polymerase ε’s 
ability to synthesize new DNA from the parental strand [9, 10]. DNA polymerases have 
been found to incorporate ribonucleotides at a rate of two ribonucleotides/kb, making this 
occurrence the predominant form of potential DNA damage in the cell [4]. Therefore, 
without proper extraction of these ribonucleotides, the cell could face major 
complications during DNA replication and repair. This extraction is carried out by a 
mechanism called ribonucleotide excision repair (RER) and the main protein involved in 
eukaryotic RER is RNase H2 [4].  
 In RER, RNase H2 makes a single-strand nick on the 5’ end of the ribonucleotide, 
leaving a 3’ OH upstream of the ribonucleotide that DNA polymerase can polymerize to. 
When this occurs, the strand containing the ribonucleotide is displaced, creating a flap. 
FEN1 endonuclease arrives and cuts this flap and finally DNA ligase attaches the two 
ends together [4]. In an in vitro study, RNase H2 has been shown to excise only single-
embedded ribonucleotides in the genome, whereas RNase H1 excises ribonucleotides in 
stretches of four or more [7]. However no studies have shown the substrate specificities 
of RNase H’s in vivo. Another DNA repair mechanism in the cell is nucleotide excision 
repair, or NER. NER removes bulky lesions in the DNA that is mostly commonly formed 
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due to ultraviolet exposure [8]. These bulky lesions primarily consist of cyclobutane 
pyrimidine dimers (CPD), however NER has been found to potentially recognize any 
damage that causes major distortion of the double helix [11]. In NER, the DNA is incised 
on both sides of the lesion and removes a 25-30 nucleotide-long fragment, which is 
followed by repair synthesis and ligation by DNA polymerase and ligase. NER has 
recently been discovered to play a role in the removal of ribonucleotides in prokaryotic 
genomes, but it has not yet been uncovered whether NER proteins in eukaryotes, such as 
its key protein RAD14, also play a role in eukaryotic ribonucleotide excision repair [12, 
13].  
 When genes encoding RNase develop a mutation that affects RNase H’s function, 
this can lead to a serious neurological disorder called Aicardi-Goutiѐres syndrome 
(AGS), which has symptoms resembling a brain viral infection [5]. AGS can cause early 
progressive encephalopathy, intercerebral calcifications, and elevated levels of white 
blood cells and interferon-α in the cerebrospinal fluid [4, 5]. Children having this disorder 
exhibit lack of progression in motor, language, and social proficiency. AGS does not 
have a cure at this time and method of pathogenicity is still uncertain [14]. AGS is a very 
rare genetic disorder, but due to its pathogenic similarity to acquired autoimmune 
diseases such as lupus and congenital HIV, it is projected that illustrating the genetics 
behind AGS will ultimately elucidate the pathogenesis of the aforementioned disorders 
[6]. The most well-known disorder that is associated with defective NER is Xeroderma 
Pigmentosum (XP), an autosomal recessive disease in which the patients afflicted are 
dangerously sensitive to sunlight that make them highly susceptible to skin cancer, while 
exhibiting other neurological defects as well [11]. Other disorders associated with NER 
deficiency include Cockayne syndrome (CS), a severe neurological and developmental 
disorder, and trichothiodystrophy (TTD), a rare autosomal recessive disorder in which the 
symptoms can range from brittle hair to considerable developmental defects and high 
child mortality [15]. 
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 In our study, we will determine the in vivo substrate specificity of RNase H2 in 
RER and also whether RAD14, the main protein in nucleotide excision repair, can remove 
ribonucleotides as well. We hypothesize that both RNase H2 and RAD14 are able to 




















MATERIALS AND METHODS 
 
Step 1: 
S. cerevisiae strains used in this study and their genotype are listed in Table 1. 
First, we transformed Leu
-
 yeast cells, which have a leu2 disrupted by a HO cut-site, with 
RNA-containing oligonucleotides by inducing a double-strand break (DSB) at the locus 
by expression of HO endonuclease under the control of pGAL. To restore this site, we 
introduced paired and mispaired ribonucleotide-embedded oligonucleotides into the 
genome to function as a template for DSB repair. When the HO cut-site was repaired 
using these oligonucleotides, a StuI restriction enzyme site was created in the LEU2 gene. 
This site assists us in determining whether RNase H type 2 and/or RAD14 play a role in 
removing ribonucleotides from DNA. The oligonucleotides used for DSB repair include 
one containing only DNA nucleotides, another containing a mispaired ribonucleotide 
within the StuI site sequence, another containing a paired ribonucleotide near the StuI 
site, another containing a stretch of two ribonucleotides near the StuI site, and lastly one 
containing a stretch of three ribonucleotides near the StuI site (Figure 1).  
 Four mutant strains of Saccharomyces cerevisiae were used: wild-type, rnh201, 
rad14, and rnh201 rad14. The wild-type is used as the control, the rnh201 mutant cannot 
form RNase H2 proteins, the rad14 mutant cannot form RAD14 proteins, and the double 
mutant is not able to form either RNase H2 or RAD14, which is used to determine 




Steps 2 and 3: 
  Once the oligonucleotides have been transformed into the cells, we amplified the 
LEU2 gene by using PCR (polymerase chain reaction). We first digest the PCR product 
with BamH1 restriction enzyme, which will allow us to confirm that the oligonucleotides 
we introduced were used as template for double strand break repair at the HO site since 
the BamH1 site is positioned directly at the break site. Then, we digested the PCR 
product with the StuI restriction enzyme. The StuI site is only generated if the 
oligonucleotides we introduced are present in the genome unharmed. However, if the 
ribonucleotide(s) is removed from the sequence, meaning they were removed by a protein 
other than RNase H2 or RAD14, then the site would not be present in the LEU2 gene. 
Based on the percentage of StuI sites cut, we are able to determine the role that RNase H2 
and/or RAD14 play in ribonucleotide excision repair.  
 
Strain Genotype 
WT FRO-767,768 (alf Δho Δhml::ADE1 MATa-inc Δhmr::ADE1 ade1 leu2-
3,112 lys5 trp1::hisG ura3-52 ade3::GAL::HO leu2::HOcs 
Δmata::hisG) 
rnh201 FRO-984,985 (FRO-767,768 Δrnh201::kanMX4) 
rad14 YS-388,389 (FRO-767,768 Δrad14::kanMX4) 
rnh201 rad14 YS-390,391 (FRO-767,768 Δrnh201::hygMX4 Δrad14::kanMX4) 
Table 1. Saccharomyces cerevisiae strains used in this study with genotypes. 
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Figure 1. Different oligonucleotide substrates used as a template for DNA double strand 
break repair. Repair occurred at the HO site, transforming the Leu
- 
cells back to Leu
+
. 
LEU2.R1m signifies a single mispaired RNA-containing oligonucleotide, 
LEU2.D1mR1p signifies a single-paired RNA-containing oligonucleotide, 
LEU2.D1mR2p signifies a two-paired RNA-containing oligonucleotide, and 
LEU2.D1mR3p signifies a three-paired RNA-containing oligonucleotide. The green line 










The StuI site is present in the genome only if the DNA has not been targeted by 
any proteins for excising ribonucleotides. The p-values are determined by comparing 
each strain to the wild-type. All strains that were repaired using the DNA oligonucleotide 
exhibit high percentages of StuI sites, similar to what is seen in the wild-type (Table 2 
and Figure 2).  
In the single mispaired RNA-containing oligonucleotide (LEU2.R1m), rnh201 
exhibits a significantly higher number of StuI sites compared to that of the wild-type, 
rad14 does not exhibit a significant change in frequency, and the double mutant (rnh201 
rad14) is found to have a statistical difference as well.  
In the single paired RNA-containing oligonucleotide (LEU2.D1mR1p), rnh201 
and rad14 exhibit statistically higher percentages of StuI sites when compared to that of 
the wild-type, and the double mutant exhibits the same significance as well. In the two-
paired RNA-containing oligonucleotide (LEU2.D1mR2p), rnh201 and the double mutant 
were found to have a statistically higher percentage of StuI sites as compared to that of 
the wild-type, whereas the rad14 mutant did not show a significant difference. As for the 
three-paired RNA-containing oligonucleotide (LEU2.D1mR3p), again rnh201 and the 
double mutant showed a significantly higher percentage of StuI sites as compared to that 





Percentage of StuI Cut Leu
+
 Transformants 
WT rnh201 rad14 rnh201 rad14 
LEU2.D1m 
(n=4) 
73% (67-88) 73% (70-83) 79% (65-92) 78% (70-88) 
NA p = 1.0000 p = 0.7715 p = 0.5566 
LEU2.R1m 
(n=6) 
48% (40-58) 68% (46-75) 50% (40-60) 70% (65-75) 
NA p = 0.0198 p = 0.7384 p = 0.0049 
LEU2.D1mR1p 
(n=6) 
35% (20-40) 90% (75-100) 60% (42-70) 98% (79-100) 
NA p = 0.0050 p = 0.0050 p = 0.0050 
LEU2.D1mR2p 
(n=4) 
35% (25-45) 53% (45-60) 30% (15-40) 55% (50-55) 
NA p = 0.0421 p = 0.4651 p = 0.0286 
LEU2.D1mR3p 
(n=6*) 
25% (8-33) 41% (40-45) 23% (17-36) 43% (33-64) 
NA p = 0.0047 p = 0.6825 p = 0.0059 
Table 2. Correction of StuI site in Leu
+
 cells. Median percentages of StuI cut Leu
+
 
transformants from 4-6 independent transformations are shown with ranges in 
parentheses or as bars. For each independent transformation, 10 to 20 Leu
+
 transformants 
were randomly selected for analysis. LEU2.D1m is the DNA-only control. 
Transformation with no oligo gave no Leu
+
 transformants. Mann-Whitney U test was 
implemented for statistical analysis. Listed P-values are from tests against the WT. P-






Figure 2. Correction of StuI site in Leu
+
 cells in bar graph form. Median percentages of 
StuI cut Leu
+
 transformants from 4-6 independent transformations are shown as bars. For 
each independent transformation, 10 to 20 Leu
+
 transformants were randomly selected for 
analysis. LEU2.D1m is the DNA-only control. Transformation with no oligo gave no 
Leu
+
 transformants. P-values determined from tests against the WT. Mann-Whitney U 






The DNA-only oligonucleotide successfully exhibits high percentages for number 
of StuI sites cut because the proteins should not be targeting the strand as no 
ribonucleotides are present (Figure 2 and Table 2).  Our results have confirmed that 
RNase H2 targets a single paired and mispaired ribonucleotide in vivo. We also found 
that RNase H2 targets RNA in a stretch of 2 and 3 ribonucleotides in vivo (Figure 2 and 
Table 2).  
As for the involvement of NER enzymes in excising ribonucleotides, results show 
that RAD14 targets a single paired ribonucleotide, but does not recognize a mispaired 
ribonucleotide or stretches of 2-3 ribonucleotides in vivo. Therefore, we have concluded 
that RER and NER work in coordination in the cell to remove single-paired 
ribonucleotides in eukaryotes. Our future directions include knocking out RNase H1, the 
less-involved protein in eukaryotic RER, and observing how this affects the excision of 
single-paired, two-paired, and three-paired ribonucleotides from the yeast Saccharomyces 
cerevisiae genome.  
This study helps illustrate the mechanism of RER and NER by demonstrating the 
substrate specificity of the RNase H enzymes as well as RAD14 of NER in a yeast 
eukaryotic cell. This study will eventually assist the scientific community in finding 
potential treatments to diseases such as AGS and XP in the future, while additionally 
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